Delivery Order SPE2DR25D3304-SPE2DR26F47S6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,623.33 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Lo Loestrin Fe 1-10 tablets (28-count packages). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of December 9, 2025. The order will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Lo Loestrin Fe 1/10 tablets in 28-count packaging. This is a firm fixed-price delivery order with a ceiling value of $1,226.80, with an ultimate completion date of November 18, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lo Loestrin Fe 1-10 tablets in 28-count packaging, with a ceiling value of $2,225.65. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Lo Loestrin Fe 1-10 tablets in a 28-tablet package configuration. This firm fixed price delivery order, valued at $1,966.22, represents a non-competitive set-aside award and is scheduled for completion by November 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $4,534.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on December 10, 2025, with an ultimate completion date of December 11, 2025. This is a non-set-aside, competitively awarded contract with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,160.66 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,247.15 on July 21, 2025, for the supply of Lo Loestrin FE 1-10 tablets in 28-count packages. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Lo Loestrin Fe 1-10 tablets in quantities of 28 units. This firm fixed-price delivery order, valued at $3,510.85, represents a non-competitive set-aside award and is scheduled for completion by December 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The Defense Logistics Agency awarded a $2,386.52 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on May 20, 2025, with an ultimate completion date of May 21, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,133.96 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was competitively awarded with no set-aside...
- SPE2DR25D3304Indefinite Delivery Contract
- SPE2DR25D3304-SPE2DR26F47S6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lo Loestrin Fe 1-10 tablets (28-count packaging) under a firm fixed-price contract with a ceiling value of $1,074.58. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 2, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, holds a significant position as a critical vendor for federal medical procurement. The company's DLA contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for hormone therapy medication reflects the company's established role in supplying comprehensive pharmaceutical products to meet military healthcare procurement requirements through competitive, firm fixed-price delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/30/25 |